doi:10.1002/jps.22076 Baertschi SW, Clapham D, Foti C et al (2013) Implications of in-use photostability: proposed guidance for photostability testing and labeling to support the administration of photosensitive pharmaceutical products, part 1: drug products administered by injection
The core concern is that allowing compounding pharmacies to produce BPC-157 might create the impression that the compound has been proven both safe and effective when, in reality, the scientific evidence behind it remains limited
3.5 cm (placebo) Cardiometabolic Benefits: Improvements in blood pressure, lipids, and glycemic parameters Safety: GI events dose-dependent
I think the interest is very understandable
Once thawed: Centrifuge briefly (30 seconds at 10,000 rpm) to collect any condensation from the tube walls Prepare fresh dilutions in the desired experimental buffer (PBS, cell culture media, etc.) Maintain on ice during experiment setup Use within 24 hours of dilution
Administration and Dosing Glow Blend protocols are customized to each patient, so there is no universal dosage or one-size-fits-all treatment
